Galectins Are Central Mediators of Immune Escape in Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers and is highly immune tolerant. Although there is immune cell infiltration in PDAC tissues, most of the immune cells do not function properly and, therefore, the prognosis of PDAC is very poor. Galectins are carbohydrate-bindin...
Main Authors: | Zhengting Jiang, Wenjie Zhang, Gengyu Sha, Daorong Wang, Dong Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/22/5475 |
Similar Items
-
Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities
by: Ana Bogut, et al.
Published: (2023-10-01) -
Role of Galectins in Multiple Myeloma
by: Paola Storti, et al.
Published: (2017-12-01) -
Galectins as Checkpoints of the Immune System in Cancers, Their Clinical Relevance, and Implication in Clinical Trials
by: Daniel Compagno, et al.
Published: (2020-05-01) -
Interplay in galectin expression predicts patient outcomes in a spatially restricted manner in PDAC
by: Oladimeji Abudu, et al.
Published: (2024-03-01) -
Galectins and cutaneous immunity
by: Huan-Yuan Chen, et al.
Published: (2012-12-01)